Belite Bio, Inc

belitebio.com

What Do They Do?

Develops oral drug candidates for retinal diseases, including Stargardt disease and geographic atrophy. Its pipeline also includes an oral compound for metabolic diseases.

How Do They Make Money?

No revenue reported yet.

Financial Snapshot

Last updated: 10/28/2026

Size Last 4 quarters

Revenue
Net Income

Growth FY2025

Revenue Growth: N/A
EPS Growth

Profitability

Gross Margin
Operating Margin
Net Income Margin

Cash flow

Free Cash Flow

Balance sheet

Cash: N/A
Debt to Equity

Valuation Today

Market Cap: $5.93B
P/E

Company Facts

Industry: Pharmaceutical Preparations
Incorporated
Headquarters
Employees

Comments